Abstract
Summary
LPI (LP Information)' newest research report, the “Sartans API Industry Forecast” looks at past sales and reviews total world Sartans API sales in 2022, providing a comprehensive analysis by region and market sector of projected Sartans API sales for 2023 through 2029. With Sartans API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sartans API industry.
This Insight Report provides a comprehensive analysis of the global Sartans API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sartans API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sartans API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sartans API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sartans API.
The global Sartans API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sartans API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sartans API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sartans API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sartans API players cover Pfizer, Novartis, Merck, AstraZeneca, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer and GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Sartans API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Valsartan
Irbesartan
Telmisartan
Losartan
Others
Segmentation by application
Anti-Hypertension
Anti-Viral
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Novartis
Merck
AstraZeneca
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Xianju Pharma
Menovo
Tianyu Pharma
Starry Pharma
Huahai Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sartans API market?
What factors are driving Sartans API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sartans API market opportunities vary by end market size?
How does Sartans API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Sartans API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sartans API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sartans API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sartans API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sartans API.
The global Sartans API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sartans API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sartans API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sartans API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sartans API players cover Pfizer, Novartis, Merck, AstraZeneca, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer and GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Sartans API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Valsartan
Irbesartan
Telmisartan
Losartan
Others
Segmentation by application
Anti-Hypertension
Anti-Viral
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Novartis
Merck
AstraZeneca
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Xianju Pharma
Menovo
Tianyu Pharma
Starry Pharma
Huahai Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sartans API market?
What factors are driving Sartans API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sartans API market opportunities vary by end market size?
How does Sartans API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sartans API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Sartans API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Sartans API by Country/Region, 2018, 2022 & 2029
2.2 Sartans API Segment by Type
2.2.1 Valsartan
2.2.2 Irbesartan
2.2.3 Telmisartan
2.2.4 Losartan
2.2.5 Others
2.3 Sartans API Sales by Type
2.3.1 Global Sartans API Sales Market Share by Type (2018-2023)
2.3.2 Global Sartans API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Sartans API Sale Price by Type (2018-2023)
2.4 Sartans API Segment by Application
2.4.1 Anti-Hypertension
2.4.2 Anti-Viral
2.4.3 Others
2.5 Sartans API Sales by Application
2.5.1 Global Sartans API Sale Market Share by Application (2018-2023)
2.5.2 Global Sartans API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Sartans API Sale Price by Application (2018-2023)
3 Global Sartans API by Company
3.1 Global Sartans API Breakdown Data by Company
3.1.1 Global Sartans API Annual Sales by Company (2018-2023)
3.1.2 Global Sartans API Sales Market Share by Company (2018-2023)
3.2 Global Sartans API Annual Revenue by Company (2018-2023)
3.2.1 Global Sartans API Revenue by Company (2018-2023)
3.2.2 Global Sartans API Revenue Market Share by Company (2018-2023)
3.3 Global Sartans API Sale Price by Company
3.4 Key Manufacturers Sartans API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sartans API Product Location Distribution
3.4.2 Players Sartans API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sartans API by Geographic Region
4.1 World Historic Sartans API Market Size by Geographic Region (2018-2023)
4.1.1 Global Sartans API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Sartans API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Sartans API Market Size by Country/Region (2018-2023)
4.2.1 Global Sartans API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Sartans API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Sartans API Sales Growth
4.4 APAC Sartans API Sales Growth
4.5 Europe Sartans API Sales Growth
4.6 Middle East & Africa Sartans API Sales Growth
5 Americas
5.1 Americas Sartans API Sales by Country
5.1.1 Americas Sartans API Sales by Country (2018-2023)
5.1.2 Americas Sartans API Revenue by Country (2018-2023)
5.2 Americas Sartans API Sales by Type
5.3 Americas Sartans API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sartans API Sales by Region
6.1.1 APAC Sartans API Sales by Region (2018-2023)
6.1.2 APAC Sartans API Revenue by Region (2018-2023)
6.2 APAC Sartans API Sales by Type
6.3 APAC Sartans API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sartans API by Country
7.1.1 Europe Sartans API Sales by Country (2018-2023)
7.1.2 Europe Sartans API Revenue by Country (2018-2023)
7.2 Europe Sartans API Sales by Type
7.3 Europe Sartans API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sartans API by Country
8.1.1 Middle East & Africa Sartans API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Sartans API Revenue by Country (2018-2023)
8.2 Middle East & Africa Sartans API Sales by Type
8.3 Middle East & Africa Sartans API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sartans API
10.3 Manufacturing Process Analysis of Sartans API
10.4 Industry Chain Structure of Sartans API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sartans API Distributors
11.3 Sartans API Customer
12 World Forecast Review for Sartans API by Geographic Region
12.1 Global Sartans API Market Size Forecast by Region
12.1.1 Global Sartans API Forecast by Region (2024-2029)
12.1.2 Global Sartans API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sartans API Forecast by Type
12.7 Global Sartans API Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Sartans API Product Portfolios and Specifications
13.1.3 Pfizer Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Sartans API Product Portfolios and Specifications
13.2.3 Novartis Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Sartans API Product Portfolios and Specifications
13.3.3 Merck Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Sartans API Product Portfolios and Specifications
13.4.3 AstraZeneca Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Sartans API Product Portfolios and Specifications
13.5.3 Eli Lilly Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Sanofi
13.6.1 Sanofi Company Information
13.6.2 Sanofi Sartans API Product Portfolios and Specifications
13.6.3 Sanofi Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanofi Main Business Overview
13.6.5 Sanofi Latest Developments
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Information
13.7.2 Bristol-Myers Squibb Sartans API Product Portfolios and Specifications
13.7.3 Bristol-Myers Squibb Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bristol-Myers Squibb Main Business Overview
13.7.5 Bristol-Myers Squibb Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Sartans API Product Portfolios and Specifications
13.8.3 Bayer Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Sartans API Product Portfolios and Specifications
13.9.3 GSK Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Teva Pharmaceutical
13.10.1 Teva Pharmaceutical Company Information
13.10.2 Teva Pharmaceutical Sartans API Product Portfolios and Specifications
13.10.3 Teva Pharmaceutical Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Pharmaceutical Main Business Overview
13.10.5 Teva Pharmaceutical Latest Developments
13.11 Xianju Pharma
13.11.1 Xianju Pharma Company Information
13.11.2 Xianju Pharma Sartans API Product Portfolios and Specifications
13.11.3 Xianju Pharma Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Xianju Pharma Main Business Overview
13.11.5 Xianju Pharma Latest Developments
13.12 Menovo
13.12.1 Menovo Company Information
13.12.2 Menovo Sartans API Product Portfolios and Specifications
13.12.3 Menovo Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Menovo Main Business Overview
13.12.5 Menovo Latest Developments
13.13 Tianyu Pharma
13.13.1 Tianyu Pharma Company Information
13.13.2 Tianyu Pharma Sartans API Product Portfolios and Specifications
13.13.3 Tianyu Pharma Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Tianyu Pharma Main Business Overview
13.13.5 Tianyu Pharma Latest Developments
13.14 Starry Pharma
13.14.1 Starry Pharma Company Information
13.14.2 Starry Pharma Sartans API Product Portfolios and Specifications
13.14.3 Starry Pharma Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Starry Pharma Main Business Overview
13.14.5 Starry Pharma Latest Developments
13.15 Huahai Pharmaceutical
13.15.1 Huahai Pharmaceutical Company Information
13.15.2 Huahai Pharmaceutical Sartans API Product Portfolios and Specifications
13.15.3 Huahai Pharmaceutical Sartans API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Huahai Pharmaceutical Main Business Overview
13.15.5 Huahai Pharmaceutical Latest Developments
14 Research Findings and Conclusion